Published in Cancer on March 09, 2016
Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014. JAMA (2017) 2.63
Melanoma burden and recent trends among non-Hispanic whites aged 15-49years, United States. Prev Med (2016) 0.91
Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world? Clin Mol Hepatol (2017) 0.88
Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-catenin. Hepatology (2016) 0.81
The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA. Nat Rev Urol (2016) 0.81
Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969-2020. Prev Chronic Dis (2016) 0.80
Incidence of Hepatocellular Carcinoma in all 50 United States, From 2000 Through 2012. Gastroenterology (2016) 0.79
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. J Natl Cancer Inst (2017) 0.78
Colorectal Cancer in African Americans: An Update. Clin Transl Gastroenterol (2016) 0.78
Cancer incidence and survival trends by subtype using data from the Surveillance Epidemiology and End Results Program, 1992-2013. Cancer Epidemiol Biomarkers Prev (2016) 0.77
(18)F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed? Eur J Nucl Med Mol Imaging (2017) 0.77
Autophagy in the liver: cell's cannibalism and beyond. Arch Pharm Res (2016) 0.76
Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2. Carcinogenesis (2016) 0.76
Mailed Outreach Program Increases Ultrasound Screening of Patients with Cirrhosis for Hepatocellular Carcinoma. Gastroenterology (2016) 0.76
A functional mTORC1 signaling is indispensable for c-Myc driven hepatocarcinogenesis. Hepatology (2017) 0.75
The cancer registry as a cancer-control tool. Cancer (2016) 0.75
Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States. PLoS One (2017) 0.75
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. World J Gastroenterol (2016) 0.75
Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget (2016) 0.75
Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma. Curr Opin Virol (2016) 0.75
Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties. Sci Rep (2017) 0.75
Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge. J Hepatocell Carcinoma (2017) 0.75
Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012. World J Gastroenterol (2016) 0.75
Cancer Mortality in Hispanic Ethnic Groups. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Following the Preclinical Data: Leveraging the Abscopal Effect More Efficaciously. Front Oncol (2017) 0.75
The Evolution of the Use of Serum Alpha-fetoprotein in Clinical Liver Cancer Surveillance. J Immunobiol (2016) 0.75
Role of Aquaporin 1 Signalling in Cancer Development and Progression. Int J Mol Sci (2017) 0.75
Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States. PLoS One (2016) 0.75
The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells. PLoS One (2017) 0.75
Robotic Assisted Laparoscopic Prostatectomy after High Intensity Focused Ultrasound Failure. Case Rep Urol (2017) 0.75
Targeting β-catenin in hepatocellular cancers induced by co-expression of mutant β-catenin and K-Ras in mice. Hepatology (2016) 0.75
Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth via HMGB1 and TLR9 interaction. Hepatology (2017) 0.75
The Role of PI3K Isoforms in Regulating Bone Marrow Microenvironment Signaling Focusing on Acute Myeloid Leukemia and Multiple Myeloma. Cancers (Basel) (2017) 0.75
Superoxide Dismutases in Pancreatic Cancer. Antioxidants (Basel) (2017) 0.75
Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanoma. Transl Lung Cancer Res (2017) 0.75
Assessing Colorectal Cancer Knowledge Among Puerto Rican Hispanics: Implications for Cancer Prevention and Control. J Community Health (2017) 0.75
Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States. BMC Public Health (2017) 0.75
Clinical characteristics of second primary pancreatic cancer. PLoS One (2017) 0.75
Impact of marital status during diagnosis on cancer-caused specific survival in acute myeloid leukemia patients: a case-control and population-based study. Oncotarget (2017) 0.75
Overview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology. Semin Intervent Radiol (2017) 0.75
Prognostic factors and outcomes of primary transitional cell carcinoma of the ureter: a population-based study. Oncotarget (2017) 0.75
Thyroid Radiation Dose to Patients From Diagnostic Radiology Procedures Over Eight Decades: 1930-2010. Health Phys (2017) 0.75
The oncologic burden of hepatitis C virus infection: A clinical perspective. CA Cancer J Clin (2017) 0.75
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. J Natl Compr Canc Netw (2017) 0.75
Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort. Int J Cancer (2017) 0.75
Immunotherapeutic Approaches to Biliary Cancer. Curr Treat Options Oncol (2017) 0.75
Seeding of a high-grade papillary urothelial carcinoma of the bladder along a nephroureterostomy tract. Radiol Case Rep (2017) 0.75
Pollution and regional variations of lung cancer mortality in the United States. Cancer Epidemiol (2017) 0.75
Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents. J Clin Transl Hepatol (2017) 0.75
The Modulating Effects of Benign Prostate Enlargement Medications on Upgrading Predictors in Patients with Gleason 6 at Biopsy. Curr Urol (2017) 0.75
A UV-Independent Topical Small-Molecule Approach for Melanin Production in Human Skin. Cell Rep (2017) 0.75
Predicting ligand-dependent tumors from multi-dimensional signaling features. NPJ Syst Biol Appl (2017) 0.75
Magnetic Resonance Imaging of Primary Hepatic Malignancies in Patients With and Without Chronic Liver Disease: A Pictorial Review. Cureus (2017) 0.75
Is nonalcoholic fatty liver disease driving the increased incidence of liver cancer? Cancer (2016) 0.75
Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009-2012. Prev Med (2017) 0.75
Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression. Oncol Lett (2017) 0.75
Pattern of distant extrahepatic metastases in primary liver cancer: a SEER based study. J Cancer (2017) 0.75
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
Permutation tests for joinpoint regression with applications to cancer rates. Stat Med (2000) 24.62
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2009) 21.55
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med (2006) 18.63
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82
Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med (2013) 13.30
Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology (2012) 10.00
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med (2014) 9.45
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer (2004) 9.24
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol (2009) 8.55
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 8.14
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst (2008) 8.14
Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72
Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res (2006) 7.67
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA (2012) 7.62
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med (2012) 7.56
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 6.99
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep (2012) 6.91
Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst (2002) 6.87
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer (2007) 6.84
Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 6.26
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 6.01
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer (2000) 4.89
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
United States Census 2000 population with bridged race categories. Vital Health Stat 2 (2003) 4.53
Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst (2001) 4.26
The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc (2008) 4.00
Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst (2004) 3.74
Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 3.65
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Estimating average annual per cent change in trend analysis. Stat Med (2009) 3.54
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med (2014) 3.50
The validity of race and Hispanic origin reporting on death certificates in the United States. Vital Health Stat 2 (2008) 3.41
Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst (1999) 3.19
Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology (2012) 3.13
Vital signs: colorectal cancer screening test use--United States, 2012. MMWR Morb Mortal Wkly Rep (2013) 3.12
The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus. Clin Infect Dis (2015) 3.08
The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis (2011) 2.96
Patient time costs associated with cancer care. J Natl Cancer Inst (2007) 2.90
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol (2013) 2.89
Screening for chronic hepatitis B among Asian/Pacific Islander populations--New York City, 2005. MMWR Morb Mortal Wkly Rep (2006) 2.82
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. J Natl Cancer Inst (2015) 2.81
Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ (2009) 2.69
Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy. Hepatology (2013) 2.66
Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology (2008) 2.66
What can we conclude from death registration? Improved methods for evaluating completeness. PLoS Med (2010) 2.61
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology (2012) 2.59
Surveillance of demographic characteristics and health behaviors among adult cancer survivors--Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ (2012) 2.57
Epidemiology of hepatocellular carcinoma in USA. Hepatol Res (2007) 2.56
Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer (1998) 2.48
Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Ann Intern Med (2013) 2.46
Vital signs: current cigarette smoking among adults aged ≥18 years with mental illness - United States, 2009-2011. MMWR Morb Mortal Wkly Rep (2013) 2.45
Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer. Br J Surg (2012) 2.25
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol (2003) 2.18
Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med (2015) 2.07
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations. JAMA (2015) 2.00
Methods for improving cancer surveillance data in American Indian and Alaska Native populations. Cancer (2008) 2.00
Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis (2010) 1.96
National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening. J Clin Oncol (2015) 1.95
Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population. Clin Gastroenterol Hepatol (2013) 1.93
Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988-1994. Am J Public Health (2004) 1.91
Cancer incidence in first generation U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and new Latinos. Cancer Epidemiol Biomarkers Prev (2009) 1.85
United States life tables, 2010. Natl Vital Stat Rep (2014) 1.84
Screening for hepatitis B virus infection in nonpregnant adolescents and adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.83
Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006. MMWR Surveill Summ (2010) 1.80
Hepatocellular carcinoma - United States, 2001-2006. MMWR Morb Mortal Wkly Rep (2010) 1.74
Methods for improving the quality and completeness of mortality data for American Indians and Alaska Natives. Am J Public Health (2014) 1.72
Care of cancer survivors. Am Fam Physician (2005) 1.65
Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation. Health Aff (Millwood) (2013) 1.63
Reprint of: Epidemiological serosurvey of Hepatitis B in China--declining HBV prevalence due to Hepatitis B vaccination. Vaccine (2013) 1.59
A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol (1994) 1.57
CDC's vision for public health surveillance in the 21st century. Introduction. MMWR Surveill Summ (2012) 1.54
Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology (2015) 1.44
Breast cancer and women's labor supply. Health Serv Res (2002) 1.42
Subsequent malignant neoplasms in cancer survivors. Cancer J (2008) 1.39
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology (2015) 1.38
Lung cancer incidence trends among men and women--United States, 2005-2009. MMWR Morb Mortal Wkly Rep (2014) 1.35
The recording of demographic information on death certificates: a national survey of funeral directors. Public Health Rep (2002) 1.32
Results from the National Breast and Cervical Cancer Early Detection Program, October 31, 1991-September 30, 1993. MMWR Morb Mortal Wkly Rep (1994) 1.25
A practical approach to using multiple-race response data: a bridging method for public-use microdata. Demography (2008) 1.24
Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population. Womens Health Issues (2005) 1.14
State-specific trends in lung cancer incidence and smoking--United States, 1999-2008. MMWR Morb Mortal Wkly Rep (2011) 1.13
Cancer survivors: living longer, and now, better. Lancet (2004) 1.12
Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United States. J Urol (2015) 1.11
Causes of death and characteristics of decedents with viral hepatitis, United States, 2010. Clin Infect Dis (2013) 1.09
Trends in Diseases Reported on US Death Certificates That Mentioned HIV Infection, 1996-2006. J Int Assoc Physicians AIDS Care (Chic) (2010) 1.07
HCV treatment--no more room for interferonologists? N Engl J Med (2013) 1.03
A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev (2014) 1.02
Associations of census-tract poverty with subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis in the United States. J Cancer Epidemiol (2014) 1.01
Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012. Hepatology (2015) 1.01
Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs. N Engl J Med (2015) 0.99
Cancer Incidence in Appalachia, 2004-2011. Cancer Epidemiol Biomarkers Prev (2016) 0.92
Incidence of testicular germ cell tumors among US men by census region. Cancer (2015) 0.90
Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969-2020. Prev Chronic Dis (2016) 0.80
Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States. Cancer Epidemiol Biomarkers Prev (2017) 0.77
Measuring chronic liver disease mortality using an expanded cause of death definition and medical records in Connecticut, 2004. Hepatol Res (2014) 0.76
Reply to lung cancer deaths averted by screening should be considered in the context of tobacco control policies. Cancer (2013) 0.75
Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010. Clin Infect Dis (2017) 0.75
Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States. Cancer (2016) 0.75
Reply to Jones. J Infect Dis (2015) 0.75
Years of Life and Productivity Loss from Potentially Avoidable Colorectal Cancer Deaths in U.S. Counties with Lower Educational Attainment (2008-2012). Cancer Epidemiol Biomarkers Prev (2016) 0.75
Lung cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study. Cancer (2017) 0.75
Alcohol Screening and Brief Intervention: A Potential Role in Cancer Prevention for Young Adults. Am J Prev Med (2017) 0.75
Disparities in breast cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study. Cancer (2017) 0.75